Overview
- Editors:
-
-
Antonio Llombart-Bosch
-
University of Valencia, Valencia, Spain
-
Vicente Felipo
-
Valencian Foundation for Biomedical Research, Valencia, Spain
Access this book
Other ways to access
Table of contents (22 papers)
-
-
- Marcos Malumbres, Sarah L. Hunt, Rocío Sotillo, Javier Martín, Jun Odajima, Alberto Martín et al.
Pages 1-11
-
-
- Heinz Höfler, Katja Specht, Karl-Friedrich Becker
Pages 19-26
-
-
-
- Juan Madoz-Gurpide, Sam M Hanash
Pages 51-58
-
- Julia D. Wulfkuhle, Cloud P. Paweletz, Patricia S. Steeg, Emanuel F. Petricoin III, Lance Liotta
Pages 59-68
-
- Antonio Llombart-Bosch, José A. López-Guerrero, Carmen Carda Batalla, Amparo Ruíz Suarí, Amando Peydró-Olaya
Pages 69-89
-
- José M. P. Freije, Milagros Balbín, Alberto M. Pendás, Luis M. Sánchez, Xose S. Puente, Carlos López-Otín
Pages 91-107
-
-
- Martin Sattler, Blanca Scheijen, Ellen Weisberg, James D. Griffin
Pages 121-140
-
-
- Emilio Barberá Guillem, James W. Sampsel
Pages 153-173
-
-
- Jonathan J. Li, Sara Antonia Li
Pages 195-207
-
-
- Nathalie Chaput, N. E. C. Schartz, Fabrice Andre, Laurence Zitvogel
Pages 215-221
-
-
- Viktor Grünwald, Manuel Hidalgo
Pages 235-246
About this book
Given the latest advances in cancer research, which includes basic research and its derived diagnostic, clinical, and therapeutic applications, the book New Trends in Cancer for the 21st Century is written by individuals such as molecular biologists, whose tasks are to decipher, after sequencing the human genome, those new genes and pathways involved in the carcinogenesis process; clinical and molecular pathologists, who apply these discoveries for the molecular diagnosis and characterization of the tumor; and clinical oncologists, who treat patients. Pharmacogenetics introduces new perspectives in the translational fields with the design of drugs against specific targets, which at this moment are in clinical trials phases. This book achieves a state of the art in every field of cancer research and discusses the new perspectives that will open the future for cancer treatment (basic research, new technologies, new drugs, therapies...). For this reason, the book is intended for pathologists, clinicians, and biologists, as well as fellows and students of physiology and medicine.
Editors and Affiliations
-
University of Valencia, Valencia, Spain
Antonio Llombart-Bosch
-
Valencian Foundation for Biomedical Research, Valencia, Spain
Vicente Felipo